142 results on '"Holzhauser, L."'
Search Results
2. (1008) Gene Expression Profiling and Dd-cfdna Performance in Heart Transplant Recipients with Neuromuscular Disorders
3. Trends in Emergency Department Use and Hospital Mortality Among Heart Transplant Recipients in the United States
4. A Transplant Center Experience with Basiliximab Induction Strategies - A Double Edged Sword?
5. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses
6. Donor-Derived Cell-Free DNA Does Not Correlate with Levels of Inflammation or Angiogenesis in a Stable Post Transplant Population
7. Absence of Aortic Valve Opening after Hemodynamic Ramp Optimization Study Does Not Impact LVAD Morbidity of Mortality
8. Optimal Cannula Positioning of Heart Mate 3 Left Ventricular Assist Device
9. Prognostication of Residual Mitral Regurgitation or Aortic Insufficiency after Invasive Hemodynamic Ramp Optimization
10. Donor-Derived Cell-Free DNA is Associated with Cardiac Allograft Vasculopathy
11. Prevalence of BK Virus Infection in a Large Heart Transplant Population
12. Lower Pulmonary Artery Pulsatility Index after Left Ventricular Assist Device Implantation is Associated with Worse Heart Failure Free Survival
13. Right Heart Function Worsens in LVAD Patients with Decoupling between Pulmonary Artery and Wedge Pressures
14. Aortic Insufficiency is Associated with Hemocompatibility-Related Adverse Events in LVAD Patients
15. Correlation of ImmuKnow Assay Levels with Rejection and Infection after Heart Transplantation
16. Ischemic Cardiomyopathy is Associated with Increased Hemocompatibility Related Adverse Events Compared to Non-Ischemic Cardiomyopathy in LVAD Patients
17. Ratio of Systolic Blood Pressure to Pulmonary Capillary Wedge Pressure Ratio: A Novel Prognostic Marker in Chronic Heart Failure
18. Longitudinal Trends in Hemodynamics Following Left Ventricular Assist Device Implantation
19. Psychosocial Contraindications to Heart Transplant Listing in an Urban Academic Medical Center
20. Deep Y-Descent in Right Atrial Waveforms is Associated with RV Dysfunction and Worse Outcome in LVAD Patients
21. What is the Role of Angiogenesis Markers in Cardiac Allograft Vasculopathy Following Heart Transplantation?
22. Omega-3 Suppresses Gastrointestinal Bleeding by Reducing Angiopoietin-2 Expression in LVAD Patients
23. Effect of Recipient Race on Quality of Donors Allocated to Heart Transplant Recipients
24. Progression of Tricuspid Regurgitation after Heart Transplantation with Concomitant Tricuspid Valve Annuloplasty
25. Heart Transplant Under Sizing is Associated with Adverse Early Hemodynamics but Does Not Affect Survival
26. Estimation of Pulmonary Capillary Wedge Pressure from the HVAD Waveform and Its Prognostic Implications
27. Worsening of Right Heart Function Following Left Ventricular Assist Device Implantation - Right Heart Catheter Waveform Analyses
28. Normalization of Metabolic Status after LVAD Implantation is Associated with Heart Failure Free Survival
29. Pulmonary Effective Arterial Elastance and Pulmonary Artery Capacitance after Left Ventricular Assist Device Implantation is Associated with Hemocompatibility-Related Adverse Events
30. Comorbidities and Biomarkers Vary between United States and Japanese LVAD Patients
31. Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices
32. Decoupling between Pulmonary Artery and Wedge Pressure is Associated with Hemocompatibility-Related Adverse Events Following LVAD Implantation
33. Cardiac Allograft Vasculopathy is Linked to Impaired Generation of Regulatory M2 Macrophages
34. TAVI in LVAD Patients with Aortic Insufficiency
35. Longitudinal Trend of Tricuspid Regurgitation Following Left Ventricular Assist Device Implantation
36. HVAD Cannula Positioning is Associated with Higher GI Bleed Rates
37. Survival and Readmission Rates Following LVAD Exchange
38. Changes in Metabolic Profiles Following Left Ventricular Assist Device Implantation
39. Circulating Monocyte Subtypes Correlate with Cardiac Allograft Vasculopathy and Differ from Atherosclerotic Disease: A Tool for Monitoring?
40. Consequence of Retained Defibrillator and Pacemaker Leads Following Heart Transplantation - An Under-Sensed Problem?
41. Gene Expression Profiling and Dd-cfdna Performance in Heart Transplant Recipients with Neuromuscular Disorders.
42. (1231) - Changes in Metabolic Profiles Following Left Ventricular Assist Device Implantation
43. (420) - Circulating Monocyte Subtypes Correlate with Cardiac Allograft Vasculopathy and Differ from Atherosclerotic Disease: A Tool for Monitoring?
44. (241) - Survival and Readmission Rates Following LVAD Exchange
45. (525) - Consequence of Retained Defibrillator and Pacemaker Leads Following Heart Transplantation - An Under-Sensed Problem?
46. FOXO3a regulates viral load and inflammation in acute Coxsackievirus B3 myocarditis - role of NK cell function
47. Persistent Cardiogenic Shock after Valve in Valve TAVR Rescued with Durable LVAD.
48. A heart transplant center experience with basiliximab induction strategies: A double edged sword?
49. Emergency Department Use and Hospital Mortality Among Heart Transplant Recipients in the United States.
50. Understanding and Investigating Sex-Based Differences in Heart Transplantation: A Call to Action.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.